10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Cytomegalovirus (CMV) infections are caused by a common herpesvirus known as Human Cytomegalovirus (HCMV). This virus infects people of all ages, and while it often produces mild or asymptomatic symptoms in healthy individuals, it can pose serious risks to those with weakened immune systems. CMV is primarily transmitted through bodily fluids such as saliva, urine, blood, and breast milk. In healthy individuals, the immune system can usually control the infection, leading to a latent phase where the virus remains dormant. However, in immunocompromised individuals, such as those with HIV/AIDS or organ transplant recipients, CMV can cause severe complications, including pneumonia, retinitis, and gastrointestinal issues. Additionally, CMV infections during pregnancy may lead to congenital disabilities in newborns. Diagnostic methods include polymerase chain reaction (PCR) tests and serological assays, while antiviral medications like ganciclovir and valganciclovir are commonly used for treatment.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria